Early appearance of neutralizing antibodies after vaccination with an inactivated hepatitis A vaccine

被引:12
作者
Flehmig, B
Staedele, H
Xueref, C
Vidor, E
Zuckerman, J
Zuckerman, A
机构
[1] PASTEUR MERIEUX SERUMS & VACCINS,MARCY LETOILE,FRANCE
[2] ROYAL FREE HOSP,SCH MED,ACAD UNIT TRAVEL MED & VACCINES,LONDON,ENGLAND
[3] ROYAL FREE HOSP,SCH MED,WHO,COLLABORATING CTR REFERENCE & RES VIRAL DIS,LONDON,ENGLAND
关键词
D O I
10.1016/S0163-4453(97)90929-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Sera from 30 subjects vaccinated with the Pasteur Merieux Serums & Vaccins (PM) inactivated hepatitis A vaccine, and from 30 subjects vaccinated with the Smithkline Beecham (SB) inactivated hepatitis A vaccine, were tested in two laboratories in order to provide comparative data on neutralizing activities of vaccine-induced antibodies, Sera were also evaluated by a modified radioimmunoassay (mRIA) and results were compared to neutralization assays results. Neutralizing antibody titres provided by the two laboratories correlated well (coefficient or correlation 0.42, P<0.001). Neutralizing antibodies were detected after vaccination with both vaccines, and the kinetics of neutralizing antibody were the same with both vaccines. The titres gradually increased between the second week after the first dose and the post-booster dose (week 28). A strong booster effect of the booster vaccine dose on neutralizing titres was observed. Significantly higher neutralizing antibody titres with the PM vaccine were observed as early immune respose on week 2 titres on both series of results. Vaccine-induced neutralizing antibody titres and vaccine-induced antibody mRIA titres correlated well (coefficient of correlation 0.82 and 0.72, respectively, P<0.0001 in both cases). These results demonstrate early appearance of neutralizing antibody at high titre with the PM vaccine.
引用
收藏
页码:37 / 40
页数:4
相关论文
共 17 条
[1]   LABORATORY TESTS AND REFERENCE REAGENTS EMPLOYED IN STUDIES OF INACTIVATED HEPATITIS-A VACCINE [J].
BINN, LN ;
MACARTHY, PO ;
MARCHWICKI, RH ;
SJOGREN, MH ;
HOKE, CH ;
BURGE, JR ;
DHONDT, E .
VACCINE, 1992, 10 :S102-S105
[2]   CHARACTERIZATION OF THE IMMUNE-RESPONSE OF VOLUNTEERS VACCINATED WITH A KILLED VACCINE AGAINST HEPATITIS-A [J].
DELEM, A ;
SAFARY, A ;
DENAMUR, F ;
HAUSER, P ;
DHONDT, E .
VACCINE, 1993, 11 (04) :479-484
[3]   SAFETY PROFILE AND IMMUNOGENICITY OF AN INACTIVATED VACCINE DERIVED FROM AN ATTENUATED STRAIN OF HEPATITIS-A [J].
ELLERBECK, EF ;
LEWIS, JA ;
NALIN, D ;
GERSHMAN, K ;
MILLER, WJ ;
ARMSTRONG, ME ;
DAVIDE, JP ;
RHOAD, AE ;
MCGUIRE, B ;
CALANDRA, G ;
PROVOST, PJ ;
MIDTHUN, K .
VACCINE, 1992, 10 (10) :668-672
[4]   LEVELS OF NEUTRALIZING AND BINDING-ANTIBODIES TO HEPATITIS-A VIRUS AFTER ONSET OF ICTERUS - A COMPARISON [J].
FLEHMIG, B ;
ZAHN, J ;
VALLBRACHT, A .
JOURNAL OF INFECTIOUS DISEASES, 1984, 150 (03) :461-461
[5]   IMMUNOGENICITY AND SAFETY OF A NEW INACTIVATED HEPATITIS-A VACCINE IN A COMPARATIVE-STUDY [J].
GOILAV, C ;
ZUCKERMAN, J ;
LAFRENZ, M ;
VIDOR, E ;
LAUWERS, S ;
RATHEAU, C ;
BENICHOU, G ;
ZUCKERMAN, A .
JOURNAL OF MEDICAL VIROLOGY, 1995, 46 (03) :287-292
[6]   PROPERTIES OF A HEPATITIS-A VIRUS CANDIDATE VACCINE STRAIN [J].
HEINRICY, U ;
STIERHOF, YD ;
PFISTERER, M ;
FLEHMIG, B .
JOURNAL OF GENERAL VIROLOGY, 1987, 68 :2487-2493
[7]   PROTECTION AGAINST HEPATITIS-A BY AN INACTIVATED VACCINE [J].
INNIS, BL ;
SNITBHAN, R ;
KUNASOL, P ;
LAORAKPONGSE, T ;
POOPATANAKOOL, W ;
KOZIK, CA ;
SUNTAYAKORN, S ;
SUKNUNTAPONG, T ;
SAFARY, A ;
TANG, DB ;
BOSLEGO, JW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (17) :1328-1334
[8]   A SIMPLE ANTIGEN-REDUCTION ASSAY FOR THE MEASUREMENT OF NEUTRALIZING ANTIBODIES TO HEPATITIS-A VIRUS [J].
KRAH, DL ;
AMIN, RD ;
NALIN, DR ;
PROVOST, PJ .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (03) :634-637
[9]   HEPATITIS-A VIRUS - CURRENT CONCEPTS OF THE MOLECULAR VIROLOGY, IMMUNOBIOLOGY AND APPROACHES TO VACCINE DEVELOPMENT [J].
LEMON, SM .
REVIEWS IN MEDICAL VIROLOGY, 1992, 2 (02) :73-87
[10]   GENETIC, ANTIGENIC AND BIOLOGICAL DIFFERENCES BETWEEN STRAINS OF HEPATITIS-A VIRUS [J].
LEMON, SM ;
JANSEN, RW ;
BROWN, EA .
VACCINE, 1992, 10 :S40-S44